British private equity investment firm
Charterhouse Capital Partners
is a
London
based
private equity
investment firm focused on investing in European mid-market companies valued between €200m and €1.5bn.
[1]
The company targets investments across the services, healthcare, specialised industrials and consumer sectors.
[2]
History
[
edit
]
Founded in 1934,
[3]
Charterhouse Capital Partners is one of Europe’s oldest private equity firms.
[4]
The firm's predecessors, then a division of
Charterhouse Bank
, began raising third party equity in 1976.
[3]
In June 2001, the firm's management completed a
management buyout
from
HSBC
to become an independent investment firm.
[5]
Notable investment activity
[
edit
]
In 2009, Charterhouse acquired
Wood Mackenzie
, selling its stake to
Hellman & Friedman
in 2012.
[6]
In 2010, the company acquired Deb Group, a skincare product group, and sold its stake in 2015 to
SC Johnson
, reportedly earning a return of over 2.5x.
[7]
In 2010, they acquired
Card Factory
, exiting its stake in 2015.
[8]
In 2011, the company acquired
ERM
, and in 2015, sold its stake to
Omers
in a deal valued at $1.7 billion.
[9]
In 2011, they acquired
Webhelp
, selling the company to
KKR
in 2015.
[10]
In 2013, Charterhouse acquired Doc Generici, an Italian pharmaceutical business, selling in 2016 to
CVC Capital Partners
.
[11]
In 2013, the company acquired
Armacell
in a €520 million deal and, in 2015, sold to a
Blackstone
led partnership in a deal valued at €960 million.
[12]
In 2015, Charterhouse acquired Mirion Technologies, a radiation detection provider, for $750 million, and in June 2021, Mirion announced it would go public after merging with a
Goldman Sachs
backed SPAC in a deal valued at $2.6 billion.
[13]
In 2016, the company acquired Cooper, a provider of generalist over-the-counter (OTC) self-care pharmaceuticals, and in March 2021 sold a majority stake to CVC.
[14]
In 2017, the company acquired a majority stake in SERB, a
Brussels
headquartered specialty pharmaceuticals company.
[15]
In 2018, they acquired a majority stake in Siaci Saint Honore (SSH), a B2B insurance broker, and sold in July 2021 to a consortium led by Burrus Group.
[16]
In March 2018, the company acquired
SLR Consulting
, a UK environmental consultancy previously owned by
3i
, becoming a major shareholder.
[17]
In June 2019, Charterhouse disposed of Italian cheese maker and distributor Nuova Castelli, which had been in their possession since 2014, and which was acquired by the
Lactalis
Group Italia.
[18]
[19]
In December 2020, SERB pharmaceuticals, backed by Charterhouse Capital Partners, agreed to purchase
Boston Scientific's
BTG
specialty pharma unit for $800m.
[20]
In the same month, the company acquired Inflexion Private Equity's minority stake in the
UK pension
provider Lane Clark & Peacock.
[21]
Also in December 2020, Charterhouse concluded a deal with French banking group
Credit Mutuel Arkea
, for a stake in the Dutch software company
Vermeg
.
[22]
In June 2022, Charterhouse disposed of SLR Consulting to a private equity fund managed by
Ares Management
.
[23]
[24]
In March 2023, in a cash and shares deal, Charterhouse sold the Irish Tarsus Group to
Informa
for a reported GBP 790m.
[25]
[26]
[27]
In April 2023, the company’s sale of French telecom’s Sagemcom to a continuation fund backed by
AlpInvest Partners
was officially recorded.
[28]
In the same month, Charterhouse confirmed their investment in a
management buyout
of France Valley Investissements, the €4 billion forestry and real assets manager, together with Guillaume Toussaint and Arno Filhol and their management team, to support France Valley’s intended launch of
ESG
-linked products.
[29]
[30]
References
[
edit
]
External links
[
edit
]
